Crossmark

PRDM16 functions as a suppressor of lung adenocarcinoma metastasis

Crossref DOI link: https://doi.org/10.1186/s13046-019-1042-1

Published Online: 2019-01-25

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Fei, Liang-Ru

Huang, Wen-Jing

Wang, Yuan

Lei, Lei

Li, Zhi-Han

Zheng, Yi-Wen

Wang, Zhao

Yang, Mai-Qing

Liu, Chen-Chen

Xu, Hong-Tao https://orcid.org/0000-0001-5062-3108
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (81372497)

Program for Liaoning Excellent Talents in University (LR2015067)
License Information

Text and Data Mining valid from 2019-01-25
More Information

Article History

Received: 13 December 2018

Accepted: 15 January 2019

First Online: 25 January 2019

Ethics approval and consent to participate

: This research was approved by the Human Research Ethics Committee of China Medical University, which is accredited by the National Council on Ethics in Human Research.

: All authors have agreed to publish this manuscript.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.